Zimbabwe's Treasury did not approve former Public Service minister Prisca Mupfumira's request to secure a National Social Security Authority loan to buy personal vehicles, a witness told court, tightening the prosecution's case in her graft trial.
Zimbabwe Treasury Denies NSSA Loan Approval
The testimony matters because it directly challenges Mupfumira's claim that Cabinet had sanctioned the borrowing, and it frames the issue as one of public procurement and financial authority rather than routine administrative discretion. If Treasury never gave the green light, the alleged use of NSSA funds for private motor vehicles would have bypassed the formal approval chain and potentially breached government spending rules.
Fidelis Ngorora, a director in the finance ministry, told chief magistrate Munamato Mutevedzi that only the Finance Ministry handles such financial matters and that the request was unlawfully made. Mupfumira and former permanent secretary Ngoni Masoka face two counts of criminal abuse of office.
For investors and creditors, the case is another reminder of governance risk in state-linked institutions such as NSSA, where lending decisions can become entangled in politics and procurement controls. Weak oversight at public funds can raise the cost of capital, erode trust in quasi-sovereign entities and complicate reform efforts aimed at restoring institutional discipline.
The case is likely to keep scrutiny on Zimbabwe's public-sector governance and on how tightly ministries control access to state-linked financing. Any further testimony over Cabinet approval and Treasury authority could determine whether the matter remains a narrow criminal case or becomes a broader test of financial accountability in government.
| Entity | Gains | Losses |
|---|---|---|
| Prosecution | ▲Stronger abuse-of-office argument | ▼None |
| Treasury/Finance Ministry | ▲Reasserted control over approvals | ▼Exposed to governance scrutiny |
| NSSA | ▲Clearer lending process standards | ▼Reputational damage from misuse allegations |
| Mupfumira and Masoka | ▲Potential chance to contest approval chain | ▼Weaker defense in graft trial |
